
Simulations Plus (SLP) Stock Forecast & Price Target
Simulations Plus (SLP) Analyst Ratings
Bulls say
Simulations Plus Inc. has demonstrated a robust performance, with a notable 22% year-over-year increase in software revenue in the third quarter, amounting to $43.8 million, alongside a 3% growth in services revenue. The company reported a significant 30% rise in the total dollar value of awarded work not yet recognized, indicating strong future revenue potential. Additionally, improved proposal activity, particularly in the biotech sector, reflects a recovering funding environment among global biopharmaceutical clients, enhancing the company's outlook in its primary markets.
Bears say
Simulations Plus Inc. experienced a decline in total revenue of 6% year-over-year for F4Q:25, despite a full-year increase of 13%, indicating potential instability in its financial performance. The company's revenue guidance for F1Q:26 anticipates a further year-over-year decline of 3% to 5%, along with a subdued full-year revenue growth forecast of only 0% to 4%, which is comparatively low against industry peers. Additionally, the loss of a significant client in the Contract Development and Manufacturing Organization (CDMO) space has contributed to a lackluster organic growth rate, reflected in consistent declines in quarterly revenue across various segments.
This aggregate rating is based on analysts' research of Simulations Plus and is not a guaranteed prediction by Public.com or investment advice.
Simulations Plus (SLP) Analyst Forecast & Price Prediction
Start investing in Simulations Plus (SLP)
Order type
Buy in
Order amount
Est. shares
0 shares